<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02938390</url>
  </required_header>
  <id_info>
    <org_study_id>Nipple Sparing Study</org_study_id>
    <nct_id>NCT02938390</nct_id>
  </id_info>
  <brief_title>Localization of Intercostal Perforating Vessels Reduces Wound Complications From Nipple Sparing Mastectomy</brief_title>
  <official_title>Ultrasound Localization of Intercostal Perforating Vessels Reduces Post-Operative Wound Complications From Nipple Sparing Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amita Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amita Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 100 women scheduled for NSM will be consented pre-operatively to participate in
      the study. US will be performed after induction of general anesthesia, prior to surgery using
      Sonositeâ„¢ portable US, 5-12mHz transducer using doppler mode.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nipple Sparing Mastectomy (NSM) has been increasingly utilized over the last ten years for
      risk-reducing surgery and surgical treatment for breast cancer. The oncologic safety has been
      well established in multiple studies in appropriately selected individuals. Additionally,
      rates of wound complications and risk factors for wound problems are well documented. The
      intercostal perforating vessels (IPV) have been demonstrated to provide a significant
      proportion of the blood supply to the nipple-areolar complex1-3. Thus, preservation of these
      vessels is essential to reducing ischemic necrosis of the nipple-areolar complex. We propose
      that localization of these vessels utilizing intra-operative ultrasound (US) will reduce
      ischemic necrosis complications of NSM.

      Objectives

        -  Demonstrate that US is an effective means of localizing the IPV intraoperatively.

        -  Evaluate the frequency of IPV preservation with the use of US.

        -  Measure rate and severity of ischemic necrosis when US is utilized to preserve IPV.

        -  Compare observed rate with historical controls.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Localization of the intercostal perforating vessels utilizing intra-operative ultrasound (US) will reduce ischemic necrosis complications of nipple sparing mastectomy.</measure>
    <time_frame>At the time of procedure</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound for localizing intercostal perforating vessels</intervention_name>
    <description>Use of an Intra-operative ultrasound during nipple sparing mastectomy to localize intercostal perforating vessels.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female subjects scheduled for nipple sparing mastectomy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females 18 years of age or older

          -  Planned nipple sparing mastectomy

        Exclusion Criteria:

          -  Contraindication to nipple sparing mastectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert O Maganini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amita Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert O Maganini, MD</last_name>
    <phone>847-755-8700</phone>
    <email>robert.maganini@amitahealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Drashti Shah</last_name>
    <phone>847.755-8349</phone>
    <email>Drashti.Shah@amitahealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AMITA Health Alexian Brothers Medical Center</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert O Maganini, MD</last_name>
      <phone>847-755-8700</phone>
      <email>robert.maganini@amitahealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Drashti Shah</last_name>
      <phone>847.755-8349</phone>
      <email>Drashti.Shah@amitahealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Robert O Maganini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Palmer JH, Taylor GI. The vascular territories of the anterior chest wall. Br J Plast Surg. 1986 Jul;39(3):287-99.</citation>
    <PMID>3730674</PMID>
  </reference>
  <reference>
    <citation>Lemaine V, Hoskin TL, Farley DR, Grant CS, Boughey JC, Torstenson TA, Jacobson SR, Jakub JW, Degnim AC. Introducing the SKIN score: a validated scoring system to assess severity of mastectomy skin flap necrosis. Ann Surg Oncol. 2015 Sep;22(9):2925-32. doi: 10.1245/s10434-015-4409-3. Epub 2015 Jan 30.</citation>
    <PMID>25634782</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2016</study_first_submitted>
  <study_first_submitted_qc>October 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2016</study_first_posted>
  <last_update_submitted>October 18, 2016</last_update_submitted>
  <last_update_submitted_qc>October 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Amita Health</investigator_affiliation>
    <investigator_full_name>Robert Maganini, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Nipple Sparing Mastectomy</keyword>
  <keyword>Ultrasound</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

